NVCR icon

NovoCure
NVCR

Overview Fund Activity

225 hedge funds and large institutions have $1.49B invested in NovoCure in 2023 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 74 increasing their positions, 62 reducing their positions, and 81 closing their positions.

Holders
225
Holders Change
-40
Holders Change %
-15.09%
% of All Funds
3.59%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
43
Increased
74
Reduced
62
Closed
81
Calls
$23.8M
Puts
$13.3M
Net Calls
+$10.5M
Net Calls Change
-$49M

Top Buyers

1
DTC
1
Deep Track Capital
Connecticut
$40.4M
2
Voloridge Investment Management
2
Voloridge Investment Management
Florida
$27.6M
3
Two Sigma Advisers
3
Two Sigma Advisers
New York
$14.9M
4
Two Sigma Investments
4
Two Sigma Investments
New York
$13.7M
5
CSS
5
Cubist Systematic Strategies
Connecticut
$12.9M

Top Sellers

1
T. Rowe Price Investment Management
1
T. Rowe Price Investment Management
Maryland
$0
2
Capital World Investors
2
Capital World Investors
California
$143M
3
Baillie Gifford & Co
3
Baillie Gifford & Co
United Kingdom
$110M
4
HIC
4
Hartline Investment Corp
Illinois
$0
5
Sumitomo Mitsui Trust Group
5
Sumitomo Mitsui Trust Group
Japan
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Northwestern Mutual Wealth Management
301
Northwestern Mutual Wealth Management
Wisconsin
– -$125 -3 Closed
TWD
302
True Wealth Design
Ohio
– -$42 -1 Closed
9 10 11 12
13